Skip to content

13G/A filed by BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND L P and 9 other reporting persons reported 6,227,034 XNCR shares, 8.4% of the class, as of 2026-09-30, in a 13G/A accepted by EDGAR 2026-11-16 21:27:24 UTC.

Accession
0000921895-26-003194
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
6,227,034
Percent of class
8.4%
Event date
2026-09-30

How the shares relate across the reporting persons: ambiguous: the persons may hold separate positions, so the group total can be higher. The page shows the largest row.

Read for the filer group BVF INC/IL.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
BIOTECHNOLOGY VALUE FUND L PPN03,263,49403,263,4943,263,4944.4%
BVF I GP LLCOO03,263,49403,263,4943,263,4944.4%
BIOTECHNOLOGY VALUE FUND II LPPN02,446,55202,446,5522,446,5523.3%
BVF II GP LLCOO02,446,55202,446,5522,446,5523.3%
Biotechnology Value Trading Fund OS LPPN0410,7480410,748410,7480.6%
BVF Partners OS Ltd.CO0410,7480410,748410,7480.6%
BVF GP HOLDINGS LLCOO05,710,04605,710,0465,710,0467.7%
BVF PARTNERS L P/ILIA,PN06,227,03406,227,0346,227,0348.4%
BVF INC/ILCO06,227,03406,227,0346,227,0348.4%
LAMPERT MARK NIN06,227,03406,227,0346,227,0348.4%